‘A two-stage prediction model for heterogeneous effects for many treatment options’ Konstantina Chalkou (University of Bern, Switzerland) XXXIst Conference of the Austro-Swiss Region [ ROeS ] of the International Biometric Society (Lausanne, Switzerland, September 9-12, 2019) DOWNLOAD
‘The need for better HTA methodology for more complex and personalised medicine’ Wim Goettsch, (Utrecht University, The Netherlands) Pharmaceutical Pricing and Reimbursement (PPRI) Conference (Vienna, Austria October 23-24, 2019) DOWNLOAD
HTx Expert Forum meeting November 25, 2019 Barcelona (Spain) – Summary poster of results DOWNLOAD
HTx Deliverable 1.1: Systematic review on how (cost-) effectiveness of combinations of health technologies, individualised/personalised treatments and treatment pathways is currently being assessed by HTA bodies DOWNLOAD
HTx Deliverable 1.3: Review on treatment modalities for patient with myelodysplastic syndrome (MDS) DOWNLOAD
HTx Deliverable 1.4: Report describing the available data sources in relapsing-remitting Multiple Sclerosis case study 3 DOWNLOAD
HTx Deliverable 4.4: Overview of the development of the use of RWD including a review of national consensus methods currently developed DOWNLOAD